GE closes in on Applicare purchase

Article

GE Medical Systems is reportedly in the final stages of closing its acquisition of Dutch PACS developer Applicare Medical Imaging, according to sources close to the companies. If the deal does go through, it will give GE an important boost in

GE Medical Systems is reportedly in the final stages of closing its acquisition of Dutch PACS developer Applicare Medical Imaging, according to sources close to the companies. If the deal does go through, it will give GE an important boost in penetrating the European market for PACS installations.

Milwaukee-based GE and Zeist-based Applicare have been in discussions for the past several months regarding a possible business combination. The companies held similar discussions in 1997 that never panned out.

Applicare was founded in 1987 but didn’t begin to achieve widespread recognition until 1994, when its RadWorks image review software was introduced. RadWorks quickly became known as one of the more robust and cost-effective PACS viewing products, and Applicare has been successful in signing numerous agreements to supply the software to such medical imaging OEMs as Kodak and Picker. Applicare also provides RadWorks to the IBM team in the DIN-PACS project.

While GE already has its own PACS product line, the NT-based Pathspeed software, Applicare will give the company better distribution in Europe. Applicare will reportedly continue to maintain its OEM relationships once the acquisition goes through. Representatives from both companies declined to comment on the sale.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.